Series C - Twist Bioscience

Series C - Twist Bioscience

Investment Firm

Overview

Twist Bioscience is a synthetic DNA production for specialty chemical compounds and drug development.

Announced Date

Jun 09, 2015

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

Illumina

Illumina

Illumina is a early_stage_venture and late_stage_venture firm.

Participant Investors

8

Investor Name
Participant Investor+ND Capital
Participant InvestorTao Venture Partners
Participant InvestorARCH Venture Partners
Participant InvestorPaladin Capital Group
Participant InvestorFidelity

Round Details and Background

Twist Bioscience raised $37000000 on 2015-06-09 in Series C

Twist Bioscience is a synthetic DNA production for specialty chemical compounds and drug development.

Company Funding History

10

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 09, 2015
Series C - Twist Bioscience
9-37.0M
Sep 30, 2014
Debt Financing - Twist Bioscience
1-10.0M
May 27, 2014
Series B - Twist Bioscience
5-26.0M
Feb 10, 2014
Series A - Twist Bioscience
3-9.1M

Recent Activity

There is no recent news or activity for this profile.